In 2024, FDA Approved Innovative Treatments for Several Complex Diseases
-
Dec 12, 2024
While the FDA’s 44 novel drug approvals as of Dec. 11 may have been lower than 2023’s 55, the agency still green-lighted some impressive agents. Among those were the first agent for a liver disease that can have serious complications; the most expensive gene therapy ever, which was approved for a disease that shortens lifespans, particularly among children; and a first-in-class therapy for a solid tumor. The agency also granted additional indications to already-available treatments, including several chimeric antigen receptor T cell (CAR-T) therapies. Industry experts spoke with AIS Health about some of the top FDA approvals of 2024. (Editor’s note: These comments have been edited for length and clarity.) Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.